Hyloris Pharmaceuticals Investor Presentation 2024

Hyloris Pharmaceuticals SA is a Belgium-based pharmaceutical company reformulating and repurposing existing chemical entities to address unmet medical needs. The company focuses on value-added cardiovascular and other therapeutic assets through lower-risk development approaches, with a growing portfolio of 30 assets and operations on Euronext Brussels.